Managing Myeloma
- 2010-06-08 - Novartis reports success in UK zoledronic acid myeloma trial
- 2010-06-08 - ASCO 2010 Multiple Myeloma Update – Day Four-Myeloma Beacon
- 2010-06-07 - Managing Myeloma: Multi-supported Educational Initiative Launches The Myeloma Treatment Resource® (MTR®) At American Society Of Clinical Oncology (ASCO)
- 2010-06-07 - Phase 2 study of carfilzomib for the treatment of multiple myeloma
- 2010-06-07 - Findings from Pomalidomide Study in Refractory Multiple Myeloma Patients Presented at ASCO
- 2010-06-07 - Onyx Expects To File Myeloma Drug At FDA This Year
- 2010-06-06 - UPDATE: Amgen's Denosumab Delays Bone Complications In Cancer Patients -Study
- 2010-06-06 - Oral Presentations Showcase Impressive Results of Bortezomib Based Therapy in Multiple Myeloma
- 2010-06-06 - Data Back Celgene's Lenalidomide in Multiple Myeloma Maintenance
- 2010-06-05 - ASCO 2010 Multiple Myeloma Update – Day One-Myeloma Beacon
- 2010-06-05 - ASCO 2010 Update: Data from Pomalidomide Study in Refractory Multiple Myeloma Patients Presented at ASCO
- 2010-06-05 - Array BioPharma's ARRY-520 Well Tolerated and Demonstrates Preliminary Activity as a Single Agent in Multiple Myeloma Patients
- 2010-06-04 - NEWS FLASH: Managing Myeloma Announces the Release of the Much Awaited Myeloma Treatment Resource Tools at ASCO. Visit Managing Myeloma's Disease Awareness Booth(#19121) for Professionals at ASCO for Demonstrations!
- 2010-06-04 - Carfilzomib In Combination With Lenalidomide And Dexamethasone Is Well-Tolerated In Multiple Myeloma Patients (ASCO 2010)
- 2010-06-03 - NEWS FLASH: Amgen's Denosumab Approved by FDA for Osteoporosis but Pricing Indicates Confidence in Acquiring Oncology Indications